KEGG Pathway Maps

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level 

 Metabolism
 
 Genetic Information Processing
 
 Environmental Information Processing
 
 Cellular Processes
 
 Organismal Systems
 
 Human Diseases
   Cancers: Overview
     05200  Pathways in cancer
     05230  Central carbon metabolism in cancer
     05231  Choline metabolism in cancer
     05202  Transcriptional misregulation in cancer
     05206  MicroRNAs in cancer
     05205  Proteoglycans in cancer
     05204  Chemical carcinogenesis
     05203  Viral carcinogenesis
   Cancers: Specific types
     05210  Colorectal cancer
     05212  Pancreatic cancer
     05225  Hepatocellular carcinoma
     05226  Gastric cancer
     05214  Glioma
     05216  Thyroid cancer
     05221  Acute myeloid leukemia
     05220  Chronic myeloid leukemia
     05217  Basal cell carcinoma
     05218  Melanoma
     05211  Renal cell carcinoma
     05219  Bladder cancer
     05215  Prostate cancer
     05213  Endometrial cancer
     05224  Breast cancer
     05222  Small cell lung cancer
     05223  Non-small cell lung cancer
   Immune diseases
     05310  Asthma
     05322  Systemic lupus erythematosus
     05323  Rheumatoid arthritis
     05320  Autoimmune thyroid disease
     05321  Inflammatory bowel disease (IBD)
     05330  Allograft rejection
     05332  Graft-versus-host disease
     05340  Primary immunodeficiency
   Neurodegenerative diseases
     05010  Alzheimer disease
     05012  Parkinson disease
     05014  Amyotrophic lateral sclerosis (ALS)
     05016  Huntington disease
     05020  Prion diseases
   Substance dependence
     05030  Cocaine addiction
     05031  Amphetamine addiction
     05032  Morphine addiction
     05033  Nicotine addiction
     05034  Alcoholism
   Cardiovascular diseases
     05418  Fluid shear stress and atherosclerosis
     05410  Hypertrophic cardiomyopathy (HCM)
     05412  Arrhythmogenic right ventricular cardiomyopathy (ARVC)
     05414  Dilated cardiomyopathy (DCM)
     05416  Viral myocarditis
   Endocrine and metabolic diseases
     04930  Type II diabetes mellitus
     04940  Type I diabetes mellitus
     04950  Maturity onset diabetes of the young
     04932  Non-alcoholic fatty liver disease (NAFLD)
     04931  Insulin resistance
     04933  AGE-RAGE signaling pathway in diabetic complications
     04934  Cushing syndrome
   Infectious diseases: Bacterial
     05110  Vibrio cholerae infection
     05120  Epithelial cell signaling in Helicobacter pylori infection
     05130  Pathogenic Escherichia coli infection
     05132  Salmonella infection
     05131  Shigellosis
     05133  Pertussis
     05134  Legionellosis
     05150  Staphylococcus aureus infection
     05152  Tuberculosis
     05100  Bacterial invasion of epithelial cells
   Infectious diseases: Viral
     05166  Human T-cell leukemia virus 1 infection
     05170  Human immunodeficiency virus 1 infection
     05162  Measles
     05164  Influenza A
     05161  Hepatitis B
     05160  Hepatitis C
     05168  Herpes simplex infection
     05163  Human cytomegalovirus infection
     05167  Kaposi sarcoma-associated herpesvirus infection
     05169  Epstein-Barr virus infection
     05165  Human papillomavirus infection
   Infectious diseases: Parasitic
     05146  Amoebiasis
     05144  Malaria
     05145  Toxoplasmosis
     05140  Leishmaniasis
     05142  Chagas disease (American trypanosomiasis)
     05143  African trypanosomiasis
   Drug resistance: Antimicrobial
     01501  beta-Lactam resistance
     01502  Vancomycin resistance
     01503  Cationic antimicrobial peptide (CAMP) resistance
   Drug resistance: Antineoplastic
     01521  EGFR tyrosine kinase inhibitor resistance
     01524  Platinum drug resistance
     01523  Antifolate resistance
     01522  Endocrine resistance
 
 Drug Development

[ BRITE | KEGG2 | KEGG ]
Last updated: August 21, 2018

» Japanese version